2018
Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates
McDonald R, Levine D, Weinreb J, Kanal E, Davenport M, Ellis J, Jacobs P, Lenkinski R, Maravilla K, Prince M, Rowley H, Tweedle M, Kressel H. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology 2018, 289: 517-534. PMID: 30204075, PMCID: PMC6209069, DOI: 10.1148/radiol.2018181151.Peer-Reviewed Original ResearchConceptsGadolinium retentionLong-term clinical manifestationsConstellation of symptomsGBCA exposureClinical manifestationsHuman tissuesSafety profileClinical diseaseInitial approvalClinical importanceGBCA administrationGreater riskBiologic activityVulnerable populationsStandardized studiesImaging modalitiesNational InstituteLinear GBCAsGBCAsSymptomsCurrent literatureDiseaseAdditional researchFuture research initiativesMedical information
2015
Nephrogenic Systemic Fibrosis
LaChance A, Abu-Alfa A, Cowper S. Nephrogenic Systemic Fibrosis. 2015, 119-136. DOI: 10.1007/978-1-4939-2395-3_12.ChaptersNephrogenic systemic fibrosisMagnetic resonance angiographySystemic fibrosisNon-renal patientsOff-label useDiverse medical specialtiesMedication toxicityRenal diseasePathological featuresRenal populationRare conditionUnsuspected conditionsLong-term effectsNew toxicitiesGadolinium retentionResonance angiographyDisease causesTreatment climateNovel diseaseMedical specialtiesFibrosisDiseasePhysiciansPharmaceutical companiesToxicity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply